Comparative study of intravenous tranexamic acid and intravenous oxytocin in the control of bleeding during hysterescopic myomectomy in women with abnormal uterin bleeding
Not Applicable
- Conditions
- Abnormal uterine and vaginal bleeding.Other abnormal uterine and vaginal bleeding
- Registration Number
- IRCT201105306563N2
- Lead Sponsor
- Vice chancellor for Research,Tabriz University Of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- Female
- Target Recruitment
- 140
Inclusion Criteria
Medium and persistent abnormal uterine bleeding; Report on transvaginal ultrasound submucosal myoma diameter 30 mm or less and grade zero or one; Exclusion criteria:
Patients with a history of heart disease; Hepatic; Diabetes;
Thromboembolism; Cancer of the uterus and cervix; Submucosal leiomyoma larger than 3 cm;
Uterine septum; pregnant women; Severe bleeding; Anti coagulation therapy
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The hemoglobin concentration. Timepoint: Six hours after surgery. Method of measurement: Blood test.
- Secondary Outcome Measures
Name Time Method Duration of surgery. Timepoint: After surgery. Method of measurement: Questionnaire.;The success of myomectomy. Timepoint: After surgery. Method of measurement: Observation.